Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 131

Similar articles for PubMed (Select 2394955)

1.

Bioavailability and pharmacokinetics of furosemide marketed in Thailand.

Kaojarern S, Poobrasert O, Utiswannakul A, Kositchaiwat U.

J Med Assoc Thai. 1990 Apr;73(4):191-7.

PMID:
2394955
2.

Comparative bioavailability of praziquantel tablets.

Kaojarern S, Nathakarnkikool S, Suvanakoot U.

DICP. 1989 Jan;23(1):29-32.

PMID:
2718480
3.

Bioavailability of phenytoin sodium capsules available in Thailand. Part II: In vivo study.

Suthisisang C, Payakachat N, Chulavatnatol S, Towanabut S.

J Med Assoc Thai. 1998 Jan;81(1):64-70.

PMID:
9470324
4.
5.

Comparative bioavailability of three commercial acetaminophen tablets.

Sotiropoulus JB, Deutsch T, Plakogiannis FM.

J Pharm Sci. 1981 Apr;70(4):422-5.

PMID:
7229957
6.

Comparative bioavailability of three commercial acetaminophen tablets.

Hekimoğlu S, Ayanoğlu-Dülger G, Hincal AA.

Int J Clin Pharmacol Ther Toxicol. 1987 Feb;25(2):93-6.

PMID:
3557735
7.

Correlation between in vitro and in vivo parameters of commercial paracetamol tablets.

Babalola CP, Oladimeji FA, Femi-Oyewo MN.

Afr J Med Med Sci. 2001 Dec;30(4):275-80.

PMID:
14510103
8.

Comparative bioavailability and in vitro characterization of two brands of diclofenac sodium enteric-coated tablets.

el-Sayed Y, Suleiman MS, Hasan M, Najib N, Muti H, Abdulhameed M.

Int J Clin Pharmacol Ther Toxicol. 1988 Oct;26(10):487-91.

PMID:
3235214
9.

Variable furosemide absorption and poor predictability of response in elderly patients.

Murray MD, Haag KM, Black PK, Hall SD, Brater DC.

Pharmacotherapy. 1997 Jan-Feb;17(1):98-106.

PMID:
9017769
10.

Influence of tablet dissolution on furosemide bioavailability: a bioequivalence study.

McNamara PJ, Foster TS, Digenis GA, Patel RB, Craig WA, Welling PG, Rapaka RS, Prasad VK, Shah VP.

Pharm Res. 1987 Apr;4(2):150-3.

PMID:
3509139
11.

Plasma pharmacokinetics of intravenous and intramuscular furosemide in the camel (Camelus dromedarius).

Ali BH, Wong YC, Alhadrami GA, Charles BG, Bashir AK.

Res Vet Sci. 1998 Jan-Feb;64(1):69-72.

PMID:
9557809
12.

A bioequivalence study of two products of furosemide tablets.

Awad R, Arafat T, Saket M, Saleh M, Gharaibeh M, Zmeili S, Sallam E, Shubair M, Qobrosi S.

Int J Clin Pharmacol Ther Toxicol. 1992 Jan;30(1):18-23.

PMID:
1551740
13.

Bioavailability of seven furosemide tablets in man.

Straughn AB, Wood GC, Raghow G, Meyer MC.

Biopharm Drug Dispos. 1986 Mar-Apr;7(2):113-20.

PMID:
3708119
14.

Assessment of pharmaceutical quality of furosemide tablets from multinational markets.

Qureshi SA, McGilveray IJ.

Drug Dev Ind Pharm. 1998 Nov;24(11):995-1005.

PMID:
9876554
15.

Comparative bioavailability of two furosemide formulations in humans.

Martin BK, Uihlein M, Ings RM, Stevens LA, McEwen J.

J Pharm Sci. 1984 Apr;73(4):437-41.

PMID:
6726624
16.

In vitro dissolution and in vivo bioavailability of commercial levothyroxine sodium tablets in the hypothyroid dog model.

Wood RW, Martis L, Gillum AW, Roseman TJ, Lin L, Bernardo P.

J Pharm Sci. 1990 Feb;79(2):124-7.

PMID:
2324959
17.

Prolonged-release hydroxypropyl methylcellulose matrix tablets of furosemide for administration to dogs.

Smal J, Marvola M, Liljequist C, Happonen I.

J Vet Pharmacol Ther. 1996 Dec;19(6):482-7.

PMID:
8971678
18.

In vitro and in vivo characteristics of some commercial phenobarbital tablets.

Sylvestri MF, Ueda CT.

Int J Clin Pharmacol Biopharm. 1979 Dec;17(12):492-7.

PMID:
528095
19.

Bioavailability of phenytoin sodium capsules available in Thailand. Part I: In vitro study.

Suthisisang C, Payakachat N.

J Med Assoc Thai. 1998 Jan;81(1):58-63.

PMID:
9470323
20.

Comparative bioavaiability of four commercial quinidine sulfate tablets.

Strum JD, Colaizzi JL, Jaffe JM, Martineau PC, Poust RI.

J Pharm Sci. 1977 Apr;66(4):539-42.

PMID:
576879
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk